InVivo Therapeutics Holdings - 14 Year Stock Price History | NVIVQ
Historical daily share price chart and data for InVivo Therapeutics Holdings since 2010 adjusted for splits and dividends. The latest closing stock price for InVivo Therapeutics Holdings as of July 19, 2024 is 0.37.
- The all-time high InVivo Therapeutics Holdings stock closing price was 425250.00 on July 22, 2013.
- The InVivo Therapeutics Holdings 52-week high stock price is 0.39, which is 5.4% above the current share price.
- The InVivo Therapeutics Holdings 52-week low stock price is 0.32, which is 13.5% below the current share price.
- The average InVivo Therapeutics Holdings stock price for the last 52 weeks is 0.37.
| InVivo Therapeutics Holdings Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2024 | 0.4032 | 0.7900 | 0.7900 | 0.2100 | 0.3700 | -49.32% |
| 2023 | 1.3140 | 2.2900 | 2.6300 | 0.6000 | 0.7300 | -68.94% |
| 2022 | 5.6753 | 13.2500 | 13.5000 | 1.7600 | 2.3500 | -79.57% |
| 2021 | 19.8492 | 20.5000 | 44.5000 | 11.5000 | 11.5000 | -43.21% |
| 2020 | 58.7016 | 157.5000 | 255.0000 | 13.2500 | 20.2500 | -87.73% |
| 2019 | 682.8869 | 1222.5000 | 1282.5000 | 97.5000 | 165.0000 | -85.43% |
| 2018 | 4858.7151 | 17062.5000 | 17062.5000 | 1050.0000 | 1132.5000 | -92.16% |
| 2017 | 47184.2629 | 77812.5000 | 92812.5000 | 14250.0000 | 14437.5000 | -81.67% |
| 2016 | 109862.3631 | 136312.0000 | 184688.0000 | 68625.0000 | 78750.0000 | -41.67% |
| 2015 | 202994.0317 | 97500.0000 | 333375.0000 | 97500.0000 | 135000.0000 | 36.36% |
| 2014 | 100752.9762 | 168000.0000 | 195000.0000 | 37500.0000 | 99000.0000 | -42.61% |
| 2013 | 197354.1667 | 131250.0000 | 425250.0000 | 82500.0000 | 172500.0000 | 32.18% |
| 2012 | 159726.0000 | 209250.0000 | 213000.0000 | 96000.0000 | 130500.0000 | -36.73% |
| 2011 | 90693.4524 | 147000.0000 | 232500.0000 | 45000.0000 | 206250.0000 | 22.22% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.000B | $0.000B |
| InVivo Therapeutics Holdings Corp. operates as a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company intends to offer three products, including a biocompatible polymer scaffolding device to treat acute wound SCI; a biocompatible hydrogel for local controlled release of methylprednisolone to treat acute SCI; and a biocompatible polymer scaffolding device seeded with autologous hNSCs to treat acute and chronic SCI. InVivo Therapeutics Holdings Corp. is based in Cambridge, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.904B | 28.13 |
| Boston Scientific (BSX) | United States | $154.336B | 38.64 |
| Stryker (SYK) | United States | $150.874B | 31.55 |
| EssilorLuxottica (ESLOY) | France | $127.819B | 0.00 |
| Medtronic (MDT) | Ireland | $113.364B | 16.07 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.609B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.066B | 26.28 |
| ResMed (RMD) | United States | $37.677B | 28.30 |
| GE HealthCare Technologies (GEHC) | United States | $34.831B | 16.54 |
| Agilent Technologies (A) | United States | $34.480B | 22.48 |
| Terumo (TRUMY) | Japan | $25.244B | 32.79 |
| Koninklijke Philips (PHG) | Netherlands | $23.274B | 16.33 |
| Insulet (PODD) | United States | $21.186B | 83.16 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.532B | 11.90 |
| Baxter (BAX) | United States | $15.914B | 11.88 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.262B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.846B | 23.82 |
| Lantheus Holdings (LNTH) | United States | $5.564B | 14.03 |
| Prestige Consumer Healthcare (PBH) | United States | $3.952B | 17.66 |
| Perrigo (PRGO) | Ireland | $3.739B | 9.48 |
| Haemonetics (HAE) | United States | $3.693B | 16.82 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.456B | 28.72 |
| ICU Medical (ICUI) | United States | $3.333B | 24.58 |
| QuidelOrtho (QDEL) | United States | $2.042B | 14.04 |
| LeMaitre Vascular (LMAT) | United States | $1.907B | 42.62 |
| AtriCure (ATRC) | United States | $1.572B | 0.00 |
| Acuren (TIC) | United States | $1.378B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.258B | 12.77 |
| Green Thumb Industries (GTBIF) | United States | $1.164B | 26.19 |
| Neogen (NEOG) | United States | $1.157B | 14.81 |
| Phibro Animal Health (PAHC) | United States | $1.135B | 14.51 |
| BioLife Solutions (BLFS) | United States | $1.085B | 0.00 |
| InMode (INMD) | Israel | $0.958B | 9.66 |
| Kestra Medical Technologies (KMTS) | United States | $0.805B | 0.00 |
| Owens & Minor (OMI) | United States | $0.712B | 5.90 |
| CeriBell (CBLL) | United States | $0.684B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.680B | 0.00 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.555B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.542B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.468B | 0.00 |
| Surmodics (SRDX) | United States | $0.429B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.363B | 13.33 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.360B | 0.00 |
| Quanterix (QTRX) | United States | $0.349B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| Cerus (CERS) | United States | $0.294B | 0.00 |
| ZimVie (ZIMV) | United States | $0.285B | 12.98 |
| Viemed Healthcare (VMD) | United States | $0.283B | 23.83 |
| Sanuwave Health (SNWV) | United States | $0.271B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.255B | 75.67 |
| Brainsway (BWAY) | Israel | $0.250B | 66.20 |
| Cresco Labs (CRLBF) | United States | $0.246B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.235B | 0.00 |
| Biote (BTMD) | United States | $0.231B | 6.49 |
| OraSure Technologies (OSUR) | United States | $0.230B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.192B | 0.00 |
| Organigram Global (OGI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.190B | 15.46 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| Exagen (XGN) | United States | $0.150B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.48 |
| MacroGenics (MGNX) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.087B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.084B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.077B | 0.00 |
| Zynex (ZYXI) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 57.57 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.86 |
| Safety Shot (SHOT) | United States | $0.030B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |